Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Anjani, Umarani Wunnava"'
Autor:
Yogesh Mahadu Khetmalis, Surendar Chitti, Anjani Umarani Wunnava, Banoth Karan Kumar, Muthyala Murali Krishna Kumar, Sankaranarayanan Murugesan, Kondapalli Venkata Gowri Chandra Sekhar
Publikováno v:
RSC Medicinal Chemistry. 13:327-342
34 imidazo[1,2-a]pyridine amides & sulfonamides are synthesized & evaluated for in vitro anti-TB activity against MTB H37Rv. IPA-6 is most potent with MIC 0.05 μg mL−1 & 125 times active than ethambutol & docked to MTB enoyl acyl protein reductase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d1dd59e1a5cd57796d88aced5b3cb41
https://doi.org/10.1039/d1md00367d
https://doi.org/10.1039/d1md00367d
Autor:
Yogesh Mahadu, Khetmalis, Surendar, Chitti, Anjani, Umarani Wunnava, Banoth, Karan Kumar, Muthyala, Murali Krishna Kumar, Sankaranarayanan, Murugesan, Kondapalli Venkata Gowri, Chandra Sekhar
Publikováno v:
RSC Med Chem
Based on the molecular hybridization strategy, thirty-four imidazo[1,2-a]pyridine amides (IPAs) and imidazo[1,2-a]pyridine sulfonamides (IPSs) were designed and synthesized. The structures of the target compounds were characterized using (1)H NMR, (1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3b83fb4562cbecaad99c011bd91314d4
https://pubmed.ncbi.nlm.nih.gov/35434623
https://pubmed.ncbi.nlm.nih.gov/35434623